Absence of health hazards associated with RDX manufacture and use.
A cross-sectional spidemiologic study was conducted to investigate a cluster of three cases of systemic lupus erythematosus at one munitions plant. The study demonstrated no excess of autoimmune disease and also failed to identify any abnormalities of the hematologic, hepatic, or renal systems in employees with 8 hour time-weighted exposures to RDX of up to 1.57 mg/m3 (average exposure was 0.28 mg/m3).
D000974:Antibodies, Antinuclear / Q000032:analysis; D004781:Environmental Exposure; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*; D008297:Male; D009574:Nitro Compounds / Q000633:toxicity; D009784:Occupational Diseases / Q000139:chemically induced*; D014227:Triazines / Q000633:toxicity*; D014303:Trinitrotoluene / Q000633:toxicity
D000974:Antibodies, Antinuclear; D009574:Nitro Compounds; D014227:Triazines; D014303:Trinitrotoluene